DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
168	エーラス・ダンロス症候群	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04036305 (ClinicalTrials.gov)	July 26, 2019	25/7/2019	Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers	Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers	Ehlers-Danlos Syndrome;Anesthesia, Local	Drug: 0.9% Sodium Chloride Injection;Drug: Lidocaine Injection 2%;Drug: Bupivacaine Injection 0.5%	Vanderbilt University Medical Center	University of Calgary	Enrolling by invitation	18 Years	N/A	All	230		United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

July 26, 2019

25/7/2019

Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers

Ehlers-Danlos Syndrome;Anesthesia, Local

Drug: 0.9% Sodium Chloride Injection;Drug: Lidocaine Injection 2%;Drug: Bupivacaine Injection 0.5%

Vanderbilt University Medical Center

University of Calgary

Enrolling by invitation

18 Years

N/A

All

230

United States